FOUR-XT: Comprehensive Hematinic for Iron Deficiency

Click Healthcare's FOUR-XT is a powerful allopathic hematinic formulation, specifically designed to combat and prevent iron deficiency anemia and associated nutritional deficiencies. Classified under the Derma and Gynecare segment, this tablet is vital for individuals with increased nutritional needs, particularly during pregnancy and lactation, or those suffering from chronic blood loss and malabsorption issues. FOUR-XT works to replenish the body?s essential building blocks for healthy blood cell production, helping to alleviate symptoms like fatigue, weakness, and poor immunity.

The high efficacy of FOUR-XT is rooted in its expertly balanced composition, which typically includes key components like Ferrous Ascorbate (a highly bioavailable form of iron), Folic Acid (Vitamin B9), and often Zinc Sulphate. Ferrous Ascorbate efficiently replenishes iron stores necessary for hemoglobin formation and oxygen transport. Folic Acid is crucial for DNA synthesis and the maturation of red blood cells (RBCs), while Zinc supports immune function, aids in wound healing, and optimizes the absorption and utilization of iron.

As a premier product within the Click Healthcare PCD Pharma Franchise Division of MK Healthcare, FOUR-XT adheres to strict manufacturing and quality assurance standards. Its formulation is particularly valuable in gynecology due to its role in preventing neural tube defects in developing fetuses and maintaining maternal iron and folate levels throughout pregnancy. The brand's commitment ensures that FOUR-XT provides a reliable, safe, and effective solution for correcting deficiencies and promoting overall tissue and cellular health.

For pharmaceutical distributors and partners, FOUR-XT represents a high-demand product in the Haematinic and Women's Health sectors. Its critical role in managing anemia and supporting healthy pregnancies makes it a cornerstone of a successful PCD portfolio. We invite you to explore franchise opportunities with Click Healthcare to bring this essential, quality-assured hematinic tablet to the market and contribute to improved public health outcomes in managing iron and folate deficiencies.